Market Overview:
The global diflorasone market is expected to grow at a CAGR of 3.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of skin diseases, rising awareness about skin care, and growing demand for ointments and creams. In terms of type, the ointment segment is expected to dominate the global diflorasone market during the forecast period owing to its high efficacy in treating various skin diseases. By application, the hospital segment is expected to account for a major share of the global diflorasone market during the forecast period as hospitals are increasingly adopting new technologies for treatment purposes.
Product Definition:
Diflorasone is a synthetic glucocorticoid which is used in the treatment of inflammatory conditions.
Ointment:
Ointment, also called as topical medication is a medicated lotion that is applied to the skin. It may be in the form of a cream or ointment and can be used for various skin conditions such as psoriasis, eczema and dermatitis. Owing to its anti-inflammatory properties it can also be used for other medical problems such as rheumatoid arthritis, osteoarthritis and inflammatory bowel disease among others.
Cream:
Cream is a topical corticosteroid used in the treatment of skin conditions such as eczema. It works by reducing redness and swelling and helps to moisturize the affected area. Corticosteroids are naturally occurring hormones that are found in animals and humans. They play an important role in maintaining balance & function of immune system by calming inflammation response.
Application Insights:
The global demand for diflorasone ointment was highest in 2017 and is expected to ascend at a CAGR of XX% over the forecast period. The growing usage of this product as an anti-inflammatory and antirheumatic drug in the hospital sector is anticipated to be a key factor driving the segment growth over the coming years. In addition, increasing awareness about this drug among patients suffering from rheumatoid arthritis is expected to further propel its demand during the forecast period.
Diflorasone cream was estimated as one of the largest products with more than 6% share of overall revenue in 2017 due largely to high usage rates across various healthcare applications including eczema treatment, psoriasis treatment, skin infections treatment and others. Increasing incidences related to skin diseases are likely drive consumer interest towards these drugs which will subsequently fuel industry expansion during future periods.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position throughout the forecast period owing to high awareness levels regarding skin disorders, availability of advanced treatment options, and presence of well-established healthcare facilities. In addition, increasing number of product launches in North America due to growing competition among key players is also likely to boost demand for diflorasone over the forecast period.
Asia Pacific is anticipated to witness significant growth during the same period owing with rapid economic development coupled with rising disposable income and improved healthcare infrastructure in emerging countries such as China and India are expected drive market growth over next eight years.
In 2016 Asman Capital Partners invested around USD X million into Allergan plc., a U.K.
Growth Factors:
- Increasing prevalence of skin diseases: The global prevalence of skin diseases is increasing every year. This is driving the demand for better and more effective treatment options, such as Diflorasone.
- Growing awareness about skin care: There is a growing awareness among people about the importance of taking care of their skin. This is leading to an increase in the demand for products that can help improve the appearance and health of their skin, such as Diflorasone.
- Rising income levels: With rising income levels, people are increasingly able to afford premium skincare products such as Diflorasone. This is contributing to its growth in popularity worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Diflorasone Market Research Report
By Type
Ointment, Cream
By Application
Hospital, Drug Store
By Companies
Sanofi, Pfizer, Novartis, Sun Pharma, Dérmico Farm, Iwaki Seiyaku, Laboratorios Dermatologicos Darier, Taiguk Pharm, Astellas, Akorn, Yoshindo, Teva, Pharma Investi, L'Oréal, Mayado Seiyaku, Teofarma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
194
Number of Tables & Figures
136
Customization Available
Yes, the report can be customized as per your need.
Global Diflorasone Market Report Segments:
The global Diflorasone market is segmented on the basis of:
Types
Ointment, Cream
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drug Store
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi
- Pfizer
- Novartis
- Sun Pharma
- Dérmico Farm
- Iwaki Seiyaku
- Laboratorios Dermatologicos Darier
- Taiguk Pharm
- Astellas
- Akorn
- Yoshindo
- Teva
- Pharma Investi
- L'Oréal
- Mayado Seiyaku
- Teofarma
Highlights of The Diflorasone Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Ointment
- Cream
- By Application:
- Hospital
- Drug Store
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Diflorasone Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Diflorasone is a corticosteroid medication used to treat various types of skin problems. It works by reducing inflammation and swelling.
Some of the major players in the diflorasone market are Sanofi, Pfizer, Novartis, Sun Pharma, D©rmico Farm, Iwaki Seiyaku, Laboratorios Dermatologicos Darier, Taiguk Pharm, Astellas, Akorn, Yoshindo, Teva, Pharma Investi, L'Or©al, Mayado Seiyaku, Teofarma.
The diflorasone market is expected to register a CAGR of 3.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Diflorasone Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Diflorasone Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Diflorasone Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Diflorasone Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Diflorasone Market Size & Forecast, 2018-2028
4.5.1 Diflorasone Market Size and Y-o-Y Growth
4.5.2 Diflorasone Market Absolute $ Opportunity
Chapter 5 Global Diflorasone Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Diflorasone Market Size Forecast by Type
5.2.1 Ointment
5.2.2 Cream
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Diflorasone Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Diflorasone Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drug Store
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Diflorasone Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Diflorasone Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Diflorasone Analysis and Forecast
9.1 Introduction
9.2 North America Diflorasone Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Diflorasone Market Size Forecast by Type
9.6.1 Ointment
9.6.2 Cream
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Diflorasone Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drug Store
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Diflorasone Analysis and Forecast
10.1 Introduction
10.2 Europe Diflorasone Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Diflorasone Market Size Forecast by Type
10.6.1 Ointment
10.6.2 Cream
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Diflorasone Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drug Store
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Diflorasone Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Diflorasone Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Diflorasone Market Size Forecast by Type
11.6.1 Ointment
11.6.2 Cream
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Diflorasone Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drug Store
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Diflorasone Analysis and Forecast
12.1 Introduction
12.2 Latin America Diflorasone Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Diflorasone Market Size Forecast by Type
12.6.1 Ointment
12.6.2 Cream
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Diflorasone Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drug Store
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Diflorasone Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Diflorasone Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Diflorasone Market Size Forecast by Type
13.6.1 Ointment
13.6.2 Cream
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Diflorasone Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drug Store
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Diflorasone Market: Competitive Dashboard
14.2 Global Diflorasone Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sanofi
14.3.2 Pfizer
14.3.3 Novartis
14.3.4 Sun Pharma
14.3.5 Dérmico Farm
14.3.6 Iwaki Seiyaku
14.3.7 Laboratorios Dermatologicos Darier
14.3.8 Taiguk Pharm
14.3.9 Astellas
14.3.10 Akorn
14.3.11 Yoshindo
14.3.12 Teva
14.3.13 Pharma Investi
14.3.14 L'Oréal
14.3.15 Mayado Seiyaku
14.3.16 Teofarma
